Results showed that knockdown of IGF2BP3 markedly reduced the tumor volumes and weights of xenografts in nude mice (Fig. 8A–C), suggesting IGF2BP3 plays an oncogenic role in GC progression in vivo. The gene discussed is IGF2BP3; the disease is gastric cancer.